Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Rate of Sickle Hemoglobin Recovery in Sickle Cell Disease Patients Undergoing Red Blood Cell (RBC) Exchange Transfusion Is Associated with Age of Patients and Number of RBC Units Transfused

John Chinawaeze Aneke, MBBS, Aliraza Rajabali, Nafanta Fadiga, Stéphanie Forté, MD MSc, FRCPC, George A. Tomlinson, PhD BSc, MSc, Christine M. Cserti-Gazdewich, BSc, MD FRCPC, Christopher J. Patriquin, MDFRCPC,MSc, Richard Ward, MSc, MRCP, FRCPath, Jacob Pendergrast, MDFRCPC, David Barth, MD FRCPC, Kevin H. M. Kuo, MDMSc,FRCPC

Blood (2019) 134 (Supplement_1): 2170.

https://doi.org/10.1182/blood-2019-122072

Published: 2019

Journal Articles

Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease

Seda S. Tolu, MD, Kai Wang, PhD, Zi Yan, Andrew Crouch, Gracy Sebastian, NP, Mark Chaitowitz, MD, Eric Fornari, MD, Evan Schwechter, MD, Joan Uehlinger, MD, Deepa Manwani, MD, Caterina P. Minniti, MD, Eric E. Bouhassira, PhD

Blood (2019) 134 (Supplement_1): 985.

https://doi.org/10.1182/blood-2019-131648

Published: 2019

Journal Articles

A Comprehensive Study of the VHL -R200W Chuvash Polycythemia Mutation Reveals a Gradual Dysregulation of the Hypoxia Pathway in Oncogenesis

Blood (2014) 124 (21): 4020.

https://doi.org/10.1182/blood.V124.21.4020.4020

Published: 2014

Journal Articles

Impact of Molecular Testing for JAK2 V617F in the Diagnosis of Polycythemia in An Integrated Community Based Hematology/Oncology Group Practice

Paul I. Roda, MD, Erlich Porat, Phd, MPH

Blood (2011) 118 (21): 846.

https://doi.org/10.1182/blood.V118.21.846.846

Published: 2011

Journal Articles

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

David B. Sykes, MD, PhD, Wilfried A. Schroyens, MD, PhD, Casey L. O'Connell, MD, Donald I. Feinstein, MD, Hasan Bazari, MD, Douglas M. Dahl, MD, Robert B. Colvin, MD, Bernard P. Paelinck, MD, PhD, Raul N. Uppot, MD, Bart Op de Beeck, MD, William Boswell, MD, Noopur S. Raje, MD, Nancy Lee Harris, MD, Eyal C. Attar, MD

Blood (2011) 118 (21): 1037.

https://doi.org/10.1182/blood.V118.21.1037.1037

Published: 2011

Journal Articles

LNK Mutation Studies In Chronic- and Blast-Phase Myeloproliferative Neoplasms and JAK2 Mutation-Negative Erythrocytosis

Terra Lasho, MT, (ASCP), Ayalew Tefferi, MD, Alessandro M. Vannucchi, MD, Christy Finke, Paola Guglielmelli, MD, Lisa Pieri, MD, Animesh Pardanani, MBBS, PhD

Blood (2010) 116 (21): 4105.

https://doi.org/10.1182/blood.V116.21.4105.4105

Published: 2010

Journal Articles

Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.

Francesco Passamonti, Susanne Schnittger, François Girodon, Jean-Jacques Kiladjian, Mary Frances McMullin, Marco Ruggeri, Eric Lippert, Alessandro Vannucchi, Carles Besses, Elisa Rumi, Chiara Elena, Torsten Haferlach, Cristiana Pascutto, Mario Cazzola

Blood (2009) 114 (22): 3904.

https://doi.org/10.1182/blood.V114.22.3904.3904

Published: 2009

Journal Articles

REP Regimen (Rituximab, Erythropoietin and Prednisone) in the Treatment of Refractory Autoimmune Hemolytic Anemia (R-AIHA).

Francesco Iuliano, Massimo Di Maio, Stefania Infusino, Alessia Perricelli, Angelo Pomillo, Antonio Russo, Amalia Giuliano, Vincenzo Pata

Blood (2008) 112 (11): 3842.

https://doi.org/10.1182/blood.V112.11.3842.3842

Published: 2008

Journal Articles

Transgenic Expression of JAK2 V617F Causes Myeloproliferative Disorders in Mice.

Shu Xing, MS, Zhizhuang Joe Zhao, Ph.D

Blood (2007) 110 (11): 2527.

https://doi.org/10.1182/blood.V110.11.2527.2527

Published: 2007

Journal Articles

Erythrocytosis after Allogeneic Bone Marrow Transplantation in the Patients with Severe Aplastic Anemia.

Soo-Jeong Park, MD, Chi-Wha Han, MD

Blood (2006) 108 (11): 5327.

https://doi.org/10.1182/blood.V108.11.5327.5327

Published: 2006

Journal Articles

Molecularly Confirmed Polycythemia Vera with Elevated Endogenous Serum Erythropoietin Level: Diagnostic Algorithms Revisited.

Paul J. Thurmes, MD, David P. Steensma, MD

Blood (2005) 106 (11): 4964.

https://doi.org/10.1182/blood.V106.11.4964.4964

Published: 2005

Journal Articles

Validation of JAK2 and New Clinical Criteria for the Diagnosis of Polycythemia Vera (PV).

Richard T. Silver, MD, Amy V. Jones, MD, Eric J. Feldman, MD, Gail J. Roboz, MD, Ellen K. Ritchie, Ph.D, Nicholas C.P. Cross, MD

Blood (2005) 106 (11): 4971.

https://doi.org/10.1182/blood.V106.11.4971.4971

Published: 2005

Journal Articles

Detection of JAK2 V617F in the Diagnosis of Erythrocytosis: Feasibility and Diagnostic Value in Clinical Practice.

Chloé James, François Delhommeau, Christophe Marzac, Irène Teyssandier, Jean-Pierre Le Couédic, Stéphane Giraudier, Lydia Roy, Patrick Saulnier, Michel Tulliez, William Vainchenker, Nicole Casadevall, Valérie Ugo

Blood (2005) 106 (11): 2595.

https://doi.org/10.1182/blood.V106.11.2595.2595

Published: 2005

Journal Articles

Red Blood Cell Precursor Mass as an Independent Determinant of Serum Erythropoietin Level

Mario Cazzola, Roberta Guarnone, Paola Cerani, Esther Centenara, Andrea Rovati, Yves Beguin

Blood (1998) 91 (6): 2139–2145.

https://doi.org/10.1182/blood.V91.6.2139

Published: 1998

NARROW

Rate of Sickle Hemoglobin Recovery in Sickle Cell Disease Patients Undergoing Red Blood Cell (RBC) Exchange Transfusion Is Associated with Age of Patients and Number of RBC Units Transfused

Long-Term Hydroxyurea Use Is Associated with Lower Levels of Hematopoietic Stem and Progenitor Cells in Patients with Sickle Cell Disease

A Comprehensive Study of the VHL -R200W Chuvash Polycythemia Mutation Reveals a Gradual Dysregulation of the Hypoxia Pathway in Oncogenesis

Impact of Molecular Testing for JAK2 V617F in the Diagnosis of Polycythemia in An Integrated Community Based Hematology/Oncology Group Practice

The TEMPI Syndrome: Telangiectasias, Elevated Erythropoietin and Erythrocytosis, Monoclonal Gammopathy, Perinephric Fluid Collections, and Intrapulmonary Shunting

LNK Mutation Studies In Chronic- and Blast-Phase Myeloproliferative Neoplasms and JAK2 Mutation-Negative Erythrocytosis

Molecular and Clinical Features of the Myeloproliferative Neoplasm Associated with JAK2 Exon 12 Mutations: a European Multicenter Study.

REP Regimen (Rituximab, Erythropoietin and Prednisone) in the Treatment of Refractory Autoimmune Hemolytic Anemia (R-AIHA).

Transgenic Expression of JAK2 V617F Causes Myeloproliferative Disorders in Mice.

Erythrocytosis after Allogeneic Bone Marrow Transplantation in the Patients with Severe Aplastic Anemia.

Molecularly Confirmed Polycythemia Vera with Elevated Endogenous Serum Erythropoietin Level: Diagnostic Algorithms Revisited.

Validation of JAK2 and New Clinical Criteria for the Diagnosis of Polycythemia Vera (PV).

Detection of JAK2 V617F in the Diagnosis of Erythrocytosis: Feasibility and Diagnostic Value in Clinical Practice.

Red Blood Cell Precursor Mass as an Independent Determinant of Serum Erythropoietin Level

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only